 DOLONEUTIN
|
Géminis Farmacéutica
|
| pregabalina |
Antiepiléptico |
| 150 mg cáps.x 30 | $50.320,25 | (20/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $24.715,25 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $22.330,73 |
|
|
|
|
| 25 mg cáps.x 30 | $11.659,66 | (20/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $5.577,94 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $4.397,58 |
|
|
|
|
| 300 mg cáps.x 30 | $72.787,00 | (20/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $27.204,08 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $31.298,79 |
|
|
|
|
| 50 mg cáps.x 30 | $26.264,40 | (20/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $11.213,56 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $10.815,16 |
|
|
|
|
| 75 mg cáps.x 15 | $18.077,80 | (20/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $7.381,77 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $10.600,45 AF $7.477,35 |
|
|
|
|
| 75 mg cáps.x 30 | $32.708,34 | (20/01/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $16.065,00 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $12.775,87 |
|
|
|
|
| |
